AGP Picks
View all

Florida Health Daily
Provided by AGP

Florida Health Daily: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Florida Health Daily.

May 2026

Mo Tu We Th Fr Sa Su
1 2 3
4 5 6 7 8 9 10
11 12 13 14 15 16 17
18 19 20 21 22 23 24
25 26 27 28 29 30 31

June 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30

July 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30 31

Press releases published on May 29, 2026

Tempest Therapeutics Announces Warrant Exercise for Approximately $2 Million in Gross Proceeds
May 29, 2026

Tempest Therapeutics Announces Warrant Exercise for Approximately $2 Million in Gross Proceeds

Indeterminate GlobeNewswire
Replimune Announces Planned RP1 BLA Resubmission Following Productive Discussion with FDA
May 29, 2026

Replimune Announces Planned RP1 BLA Resubmission Following Productive Discussion with FDA

Indeterminate GlobeNewswire
Jyong Biotech CEO Outlines FDA Pathway and Global Strategy in PharmaBoardroom Live Interview
May 29, 2026

Jyong Biotech CEO Outlines FDA Pathway and Global Strategy in PharmaBoardroom Live Interview

Indeterminate GlobeNewswire
EDAP Announces Corporate Name Change to FocalTherics™ to Reflect Exclusive Focus on High-Growth Robotic Focal Therapy
May 29, 2026

EDAP Announces Corporate Name Change to FocalTherics™ to Reflect Exclusive Focus on High-Growth Robotic Focal Therapy

Indeterminate GlobeNewswire
Aptose Biosciences Announces Update on Anticipated Timing of Closing of the Plan of Arrangement with Hanmi Pharmaceutical
May 29, 2026

Aptose Biosciences Announces Update on Anticipated Timing of Closing of the Plan of Arrangement with Hanmi Pharmaceutical

Indeterminate GlobeNewswire
Agios Provides Update on Phase 2b Trial of Tebapivat in Lower-Risk Myelodysplastic Syndromes
May 29, 2026

Agios Provides Update on Phase 2b Trial of Tebapivat in Lower-Risk Myelodysplastic Syndromes

Indeterminate GlobeNewswire
PICARD MEDICAL, INC. Issues Letter to Shareholders
May 29, 2026

PICARD MEDICAL, INC. Issues Letter to Shareholders

Indeterminate GlobeNewswire
Pharvaris to Present Clinical Data at the EAACI Annual Congress 2026
May 29, 2026

Pharvaris to Present Clinical Data at the EAACI Annual Congress 2026

Indeterminate GlobeNewswire
ENT & Allergy Associates Advances Strategic Expansion with New Facilities and Care Innovations
May 29, 2026

ENT & Allergy Associates Advances Strategic Expansion with New Facilities and Care Innovations

Indeterminate GlobeNewswire
Sequana Medical Announces Presentation on Recompensation of Decompensated Cirrhosis Following alfapump® Placement at EASL Congress 2026
May 29, 2026

Sequana Medical Announces Presentation on Recompensation of Decompensated Cirrhosis Following alfapump® Placement at EASL Congress 2026

Indeterminate GlobeNewswire
Gumitide Gummies Under Investigation: Examining Customer Complaints, Ingredients Claims and Serious Side Effects Risk
May 29, 2026

Gumitide Gummies Under Investigation: Examining Customer Complaints, Ingredients Claims and Serious Side Effects Risk

Indeterminate GlobeNewswire

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Florida Health Daily

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.